Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Tomohiro Urata"'
Autor:
Kengo Mori, Kazuya Nishii, Wataru Kitamura, Tomohiro Urata, Takahiro Baba, Hiroki Omori, Masamoto Nakanishi, Tomoki Tamura, Shoichi Kuyama
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 8, Iss , Pp 100192- (2022)
A 74-year-old woman with squamous cell lung cancer (cT3N1M0, c-stage IIIA) was treated with durvalumab after chemoradiotherapy. At the beginning of the fourth treatment, Grade 2 (Common Terminology Criteria for Adverse Events ver5.0) radiotherapy-
Externí odkaz:
https://doaj.org/article/5419b586ac3a48e88aff066fc9b1f8b9
Autor:
Masaya Abe, Nobuharu Fujii, Kentaro Mizuhara, Tomohiro Urata, Yuichi Sumii, Yuki Fujiwara, Keisuke Seike, Yasuhisa Sando, Makoto Nakamura, Keiko Fujii, Kyosuke Saeki, Yusuke Meguri, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Ken-ichi Matsuoka, Yoshinobu Maeda
Publikováno v:
Leukemia Research Reports, Vol 15, Iss , Pp 100241- (2021)
Owing to the poor prognosis of relapsed or refractory acute lymphoblastic leukemia (ALL), hematopoietic stem cell transplantation (HSCT) followed by effective salvage therapy is required. Inotuzumab ozogamicin (INO) was developed for ALL refractory t
Externí odkaz:
https://doaj.org/article/ceb19e7707c74a5d825328162843e597
Autor:
Akira Yamamoto, Hisakazu Nishimori, Toshiaki Shirai, Katsuhiro Takano, Aya Komura, Yui Kambara, Takuya Fukumi, Tomohiro Urata, Noboru Asada, Daisuke Ennishi, Keiko Fujii, Nobuharu Fujii, Ken-ichi Matsuoka, Kenji Niiya, Katsue Suzuki-Inoue, Yoshinobu Maeda
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 13, p1917-1922, 6p
Autor:
Makoto Handa, Tomohiro Urata, Kai Nakashima, Tamotsu Sugimori, Haruo Akashi, Masahiro Mikuriya
Publikováno v:
Journal of Porphyrins and Phthalocyanines. 27:314-320
Amphiphilic zinc(II) (1), nickel(II) (2), and palladium(II) (3) complexes of 1,4,8,11,15,18,22,25-octakis(1,4,7,10-tetraoxaundecyl)phthalocyanine were synthesized and characterized by elemental analysis and MALDI-TOF mass and 1H NMR spectroscopies. E
Autor:
Yuki Hirami, Midori Filiz Nishimura, Tomohiro Urata, Michiko Morimoto, Yukina Maekawa, Tadashi Yoshino, Yoshito Nishimura, Yasuharu Sato
Publikováno v:
Journal of Clinical and Experimental Hematopathology. 63(1):25-31
Intravascular large B-cell lymphoma (IVL) is a rare type of lymphoma characterized by tumor growth selectively within the vessels. The 5th edition of the World Health Organization classification defines IVL as a large B-cell lymphoma, the same as dif
Autor:
Tomohiro Urata, Kazutaka Sunami, Toshi Imai, Yuichiro Nawa, Yasushi Hiramatsu, Kazuhiko Yamamoto, Soichiro Fujii, Isao Yoshida, Tomofumi Yano, Yusuke Naoi, Kazuhiro Ikeuchi, Hiroki Kobayashi, Katsuma Tani, Shuji Momose, Jun-ichi Tamaru, Merrill Boyle, Aixiang Jiang, Yasuharu Sato, Tadashi Yoshino, Yoshinobu Maeda, David W. Scott, Daisuke Ennishi
Publikováno v:
Blood. 140:6421-6423
Autor:
Takumi Kondo, Nobuharu Fujii, Keiko Fujii, Yuichi Sumii, Tomohiro Urata, Maiko Kimura, Masayuki Matsuda, Shuntaro Ikegawa, Kana Washio, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Ken‐ichi Matsuoka, Fumio Otsuka, Yoshinobu Maeda
Publikováno v:
Transfusion. 62:1065-1072
Autor:
Yuichi Sumii, Nobuharu Fujii, Keiko Fujii, Takumi Kondo, Tomohiro Urata, Maiko Kimura, Kana Washio, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Ken‐ichi Matsuoka, Fumio Otsuka, Yoshinobu Maeda
Publikováno v:
TransfusionREFERENCES. 62(9)
For pediatric recipients, red blood cells (RBCs) are added to bone marrow (BM) collections before low RBC volume BM processing using COBE Spectra (COBE) or Spectra Optia (Optia). However, the processing efficiency of this approach has not been evalua
Autor:
Takumi, Kondo, Nobuharu, Fujii, Keiko, Fujii, Yuichi, Sumii, Tomohiro, Urata, Maiko, Kimura, Masayuki, Matsuda, Shuntaro, Ikegawa, Kana, Washio, Hideaki, Fujiwara, Noboru, Asada, Daisuke, Ennishi, Hisakazu, Nishimori, Ken-Ichi, Matsuoka, Fumio, Otsuka, Yoshinobu, Maeda
Publikováno v:
TransfusionREFERENCES. 62(5)
CD34We retrospectively collected the data from 147 consecutive apheresis procedures across 106 healthy donors and 27 patients completed between July 2016 and December 2020 at the Okayama University Hospital. All procedures were performed using the Op
Autor:
Yuki Fujiwara, Tomohiro Urata, Daigo Niiya, Tomofumi Yano, Yuichiro Nawa, Isao Yoshida, Toshi Imai, Kazutaka Sunami, Soichiro Fujii, Daisuke Ennishi, Yoshinobu Maeda, Yasushi Hiramatsu
Publikováno v:
International journal of hematology. 115(6)
Progression-free survival in patients with untreated follicular lymphoma (FL) has significantly improved with obinutuzumab plus chemotherapy followed by obinutuzumab maintenance, compared with rituximab plus chemotherapy. However, the survival outcom